Treace Medical Concepts (TMCI) Change in Receivables (2020 - 2026)

Treace Medical Concepts has reported Change in Receivables for 7 years, with the latest figure at -$11.7 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Receivables fell 25.79% year-over-year to -$11.7 million; the trailing twelve-month figure through Mar 2026 stood at -$306000.0 (down 107.25% YoY), and the FY2025 full-year result was $2.1 million, down 63.25% from the prior year.
• Change in Receivables for Q1 2026 stood at -$11.7 million, down from $9.5 million in the prior quarter.
• The five-year high for Change in Receivables was $17.2 million in Q4 2024, with the low at -$11.7 million in Q1 2026.
• Historically, Change in Receivables has averaged $966588.2 across 5 years, with a median of -$696000.0 in 2025.
• Annual changes were most pronounced in 2023 — Change in Receivables jumped 343.49% — and 2024, when it slumped 229.84%.
• Treace Medical Concepts' Change in Receivables stood at $11.1 million in 2022, then advanced by 20.95% to $13.4 million in 2023, then increased by 28.09% to $17.2 million in 2024, then plunged by 44.64% to $9.5 million in 2025, then slumped by 222.77% to -$11.7 million in 2026.
• The last three Change in Receivables figures came in at -$11.7 million (Q1 2026), $9.5 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.